A Twin-Cysteine Motif in the V2 Region of gp120 Is Associated with SIV Envelope Trimer Stabilization by Bohl, Christopher et al.
 A Twin-Cysteine Motif in the V2 Region of gp120 Is Associated with
SIV Envelope Trimer Stabilization
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Bohl, Christopher, Dane Bowder, Jesse Thompson, Levon
Abrahamyan, Sandra Gonzalez-Ramirez, Youdong Mao, Joseph
Sodroski, Charles Wood, and Shi-hua Xiang. 2013. “A Twin-
Cysteine Motif in the V2 Region of gp120 Is Associated with SIV
Envelope Trimer Stabilization.” PLoS ONE 8 (7): e69406.
doi:10.1371/journal.pone.0069406.
http://dx.doi.org/10.1371/journal.pone.0069406.
Published Version doi:10.1371/journal.pone.0069406
Accessed February 19, 2015 2:20:33 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11855743
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
A Twin-Cysteine Motif in the V2 Region of gp120 Is
Associated with SIV Envelope Trimer Stabilization
Christopher Bohl1,3, Dane Bowder1,3, Jesse Thompson1,2, Levon Abrahamyan1,3, Sandra Gonzalez-
Ramirez1,3, Youdong Mao4,5, Joseph Sodroski4,5,6,7, Charles Wood1,3, Shi-hua Xiang1,2,3*
1Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, Nebraska, United States of America, 2 School of Veterinary Medicine and Biomedical Sciences,
University of Nebraska-Lincoln, Lincoln, Nebraska, United States of America, 3 School of Biological Sciences, University of Nebraska-Lincoln, Lincoln, Nebraska, United
States of America, 4Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, 5Department of
Microbiology and Immunology, Division of AIDS, Harvard Medical School, Boston, Massachusetts, United States of America, 6Department of Immunology and Infectious
Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America, 7 Ragon Institute of Massachusetts General Hospital, Massachusetts Institute
of Technology and Harvard University, Boston, Massachusetts, United States of America
Abstract
The V1 and V2 variable regions of the primate immunodeficiency viruses contribute to the trimer association domain of the
gp120 exterior envelope glycoprotein. A pair of V2 cysteine residues at 183 and 191 (‘‘twin cysteines’’) is present in several
simian immunodeficiency viruses, human immunodeficiency virus type 2 (HIV-2) and some SIVcpz lineages, but not in HIV-1.
To examine the role of this potentially disulfide-bonded twin-cysteine motif, the cysteine residues in the SIVmac239
envelope glycoproteins were individually and pairwise substituted by alanine residues. All of the twin-cysteine mutants
exhibited decreases in gp120 association with the Env trimer, membrane-fusing activity, and ability to support virus entry.
Thus, the twin-cysteine motif plays a role in Env trimer stabilization in SIV and may do so in HIV-2 and some SIVcpz as well.
This implies that HIV-1 lost the twin-cysteines, and may have relatively unstable Env trimers compared to SIV and HIV-2.
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Introduction
It has been well established that human immunodeficiency
viruses (HIV) are derived from simian immunodeficiency viruses
(SIV) through cross-species transmission [1–4]. The introduction
of primate lentiviruses (PLV) into new host species can result in
pathogenesis. Unlike SIV in nonhuman primates, HIV-1 fre-
quently causes human immune system failure and leads to fatal
acquired immunodeficiency syndrome (AIDS) [5–7]. HIV-1 has
infected more than 60 million people and caused the AIDS-related
deaths of 25 million people globally (UNAIDS, Report on Globe
AIDS Epidemic 2010). The basis for the differences between
pathogenic HIV-1 infections in humans and the generally
apathogenic SIV infections in African monkeys is not well
understood. In the latter case, SIV and the host immune system
apparently achieve a mutual balance. However, if the host loses
the ability to control the virus, disease can result, as observed with
HIV-1 in humans [8–11]. Of interest, SIVcpz in chimpanzees,
which represents the intermediate in PLV transmission from non-
human primates to humans, can also exhibit pathogenicity in
chimpanzees resembling that of HIV-1 in humans [12–15]. Thus,
SIV infection of monkeys, SIVcpz infection of chimpanzees, and
HIV-1 infection of humans apparently represent examples of
progressively poorer host immune system control of virus and
increased pathogenicity.
The PLV, which include HIV-1, HIV-2 and SIV, are enveloped
retroviruses. The trimeric envelope glycoprotein (Env) spikes on
the virion surface are the only viral molecules making direct
contacts with host cell receptors (CD4 and a chemokine receptor
like CCR5). PLV Env evolution is driven by requirements to
mediate host cell entry and to evade host-generated neutralizing
antibodies. HIV and SIV Envs evade host immunity by employing
mechanisms such as rapid alteration of surface loops, glycan
shielding and presentation of multiple conformers, which may act
as decoys [16–22]. An understanding of HIV/SIV Env structure
has relied on X-ray crystal structures of fragments of the gp120
and gp41 subunits and on low-resolution cryo-electron micro-
scopic reconstructions [8–11]. Unfortunately, the three-dimen-
sional structure of the trimeric spike is still unknown, despite
significant effort. However, cryo-electron tomography and single-
particle electron microscopy approaches have yielded significant
insights. Lower-resolution native Env trimer architectures on
HIV-1 and SIV have been described [23–26]. It has been
suggested that the V1V2 regions are located at the membrane-
distal apex of the Env spike [23,27]. If the V1V2 regions are
deleted, the SIV Env trimer can assume a more open and flexible
structure [28]. The recently reported HIV-1 Env trimer structure
at 11-A˚ resolution shows that the V1, V2 and V3 variable regions
of the gp120 exterior Env subunit interact near the trimer axis [8–
11]. This trimer-association domain (TAD) of gp120 potentially
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regulates trimer stability and other HIV/SIV Env phenotypes
[29].
We are particularly interested in the participation of the V2
region in the trimer association domain (TAD) because so little is
known about its structure and function. However, the V2 region is
immunogenic, and in some cases serves as a target for broadly
cross-reactive neutralizing antibodies [11,30–34]. Recent data
from antibody complexes with V2 peptides indicate that the V2
region of HIV-1 can potentially assume multiple conformations,
depending on context [35,36].
Alignment of the PLV V2 sequences revealed the presence of
two conserved cysteine residues in HIV-2 and SIV strains
(Figure 1). Because these two cysteines are always either present
or absent as a pair during PLV evolution, we will refer to them as
‘‘twin cysteines’’. This distinguishes them from other cysteine
residues within the gp120 molecule, the disulfide-bonding pattern
of which is well established [37–40]. The twin cysteines in the
gp120 V2 region of most SIV and HIV-2 strains are absent in all
HIV-1 strains. We hypothesize that these twin cysteines may form
a disulfide bond that plays a role in envelope trimer stabilization.
Here, we provide data supporting this hypothesis, and show that
the twin cysteines of SIVmac239 contribute significantly to
stabilizing the non-covalent interaction of gp120 within the Env
trimer.
Materials and Methods
Cell Lines
The 293T cells used for SIV envelope expression and
recombined viruses production were grown on Dulbecco’s
modified Eagle medium (DMEM) containing 10% fetal bovine
serum and 100 mg/ml of penicillin/streptomycin at 37uC and 5%
CO2. The cell lines based on Cf2Th-CD4 cells were grown on
complete DMEM with 150 mg/ml of hygromycin medium but
supplemented with additional antibiotics, 50 mg/ml G418 for
Cf2Th-CD4/CCR5 cells, 300 ug/ml Zeocin for CfTh2-CD4/
CXCR4 cells. The TZM-bl reporter cell line (NIH AIDS
Research and Reagent Program) was used for viral infection
experiments as it expresses CD4 and CCR5, and also contains
both beta-galactosidase and luciferase reporter genes; the TZM-bl
cell line was grown in normal complete DMEM medium.
Site-directed Mutagenesis
The twin-cysteine substitution mutants (183A/C and 191C/A,
183C/A+191C/A) as well as other related mutants (192Y/A and
190R/E) were made in the pcDNA3.1(+) vector using site-directed
mutagenesis (QuikChange II XL kit from Stratagene). All
mutagenesis primers were synthesized by Integrated DNA
Technologies (IDT). DNA sequencing was used to verify all
mutations generated by the designed primers.
Envelope Expression, Processing and Shedding Assay
Gel electrophoresis was used to check the envelope glycoprotein
expression, processing and stability, and also used to separate
gp160 and gp120 Env glycoproteins. This method is based on
radioactive (35S methionine/cysteine) metabolic labeling of the
Env-expressing cells and immunoprecipitation [41]. In brief, the
Env-expressing plasmid was transfected into 293T cells. One day
after transfection, the cells were metabolically labeled with 35S-
(protein-labeling mix) (Perkin-Elmer). After overnight culturing,
the media and the cell lysates were harvested for analysis. The
radiolabeled envelope proteins were precipitated using anti-SIV
serum with Protein A-Sepharose beads, followed by SDS-PAGE
gel analysis.
Pulse-chase Labeling
The transfected 293T cells were cultured in methionine/
cysteine-free medium for 30 minutes followed by pulse labeling for
1 hour with 300 uCi of [35S]-methionine/cysteine (.1000 Ci/
mmol; NEN). The labeling medium was removed and the cells
were washed with complete medium and chased in complete
medium for 2, 4, and 8 hours. At the appropriate times, medium
was collected, clarified by micro-centrifugation, and adjusted to
1X lysis buffer containing protease inhibitors. The cells were lysed
in 1X lysis buffer containing protease inhibitors and clarified by
micro-centrifugation. Lysates were pre-cleared with normal
Figure 1. Phylogeny of the gp120 V2 region in PLVs. The Phylogenetic tree (unrooted, left panel) was constructed based on whole genome
nucleotide sequences, using a neighbor-joining method [43] and bootstrapping for 1000 steps. The associated gp120 V2 region sequence alignment
was accomplished using the Clustal W program [44]. The twin-cysteine residues are colored red and marked with a red bar, and the conserved
tyrosine (Y) in green. The residues are numbered based on the standard system, which uses HXBc2 as a reference [45]. The viral strains used for the
phylogenetic tree construction are as follows respectively: HIV-1, AF033819; HIV-2, M30502; SIVcpzANT, U42720; SIVcpzTAN, EF394356; SIVsmm,
AF4679.
doi:10.1371/journal.pone.0069406.g001
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monkey serum and viral proteins were immunoprecipitated with
SIVmac251-infected monkey serum, separated by SDS-PAGE,
and analyzed by phosphoimaging using the Discovery Series
Quantity One software (Bio-Rad).
Ligand Binding
The wild-type or a mutant envelope plasmid was transfected
into 293T cells using the Effectene transfection reagent (Qiagen).
After 2 days, the transfected cells were metabolically labeled using
35S-methionine/cysteine (1000 Ci/mmol, Perkin-Elmer) overnight
in DMEM medium free of methionine and cysteine. The medium
was collected and the cells were lysed with buffer containing a
lower NP-40 concentration. After centrifugation to remove the cell
debris, the supernatant and the collected medium were mixed for
the ligand binding experiments. The CD4 binding was carried out
by using human Ig-tagged CD4 protein (CD4-IgG2 from the NIH
AIDS Research and Reagent Program) with the radiolabeled viral
envelope glycoproteins. The bound envelope proteins were
analyzed by SDS-PAGE and exposure to X-ray film. The
assessment of gp120 binding to the co-receptor CCR5 was done
by using CF2Th-CCR5 cells in the presence of sCD4 (10 mg/ml).
The CCR5-expressing cells were incubated with the radiolabeled
gp120 envelope glycoproteins in the supernatants of Env-
expressing cells. The CCR5-expressing cells were washed, lysed,
and precipitated with HIV-1 positive pertinent sera and Protein-A
beads. The immunoprecipitates were applied to an SDS-PAGE
gel, and then visualized and quantified after exposing to X-ray film
or using a phosphoimager.
Cell Fusion Assay
The fusion abilities of all the Env mutants were measured using
TZM-bl target cells that express the HIV/SIV receptors CD4 and
coreceptor CCR5 and CXCR4. The 293T cells in 6-well plates
were co-transfected with the Env-expressing plasmids and a Tat-
expressing plasmid using Fugene6 [42] according to the manu-
facturer’s instructions. The transfected cells (effector cells) were
incubated for 24 hours, harvested and washed, then overlaid on
TZM-bl target cells seeded onto a 96-well plate to measure cell-to-
cell fusion. The fusion activity between effector and donor cells
can be readily measured by luciferase activity. After overnight co-
culturing, the cells were washed once with PBS, lysed and
luciferase activity was measured by using the Luciferase Assay
System (Promega) and the Veritas luminometer (Turner Biosys-
tems). The relative light units (RLU) representing the lumines-
cence indicated the amount of cell-cell fusion. The background
luminescence produced by co-cultured mock-transfected 293T
and TMZ-bl cells was subtracted from the RLU values observed in
wild type (wt) and mutant Env-transfected cells.
Viral Infection Analysis
The viral infection analysis was carried out using TZM-bl as
target cells. The wild-type and twin-cysteine or other Env mutants
were pseudotyped on viruses using the viral genomic backbone
plasmid pNL-4-3_GFPDEnv in transfected 293T cells. The viral
titers were measured by RT activity using liquid scintillation to
detect incorporation of H3 into newly synthesized DNA; input
virus for infections was normalized as CPM reflecting functional
reverse transcriptase in virus stocks. The infectivity of the wild-type
and mutant viruses was determined by incubating the recombi-
nant virions with TZM-bl target cells for 48 hours at 37uC. The
GFP intensity was measured using flow cytometry.
Results
Twin-cysteine SIV gp120 Mutants Exhibit Reduced
Infectivity
To investigate the role of the twin cysteines during viral
infection, we altered them in the prototypic SIV strain SIVmac239
and tested the effect of these changes on virus infectivity. The twin
cysteines were changed singly (183C/A, 191C/A) or together
(183C/A+191C/A). Additionally, we altered a conserved tyrosine
(192Y) located adjacent to the second cysteine (192Y/A) (Figure 1).
Finally, we altered the less conserved arginine (R) at position 190,
changing this residue to glutamic acid (190R/E).
The relative infectivity of the SIVmac239 V2 mutants is shown
in Figure 2. All of the twin cysteine mutants exhibited significant
reductions in infectivity. This was also true for the 192Y/A
mutant. However, the 190R/E mutant efficiently supported virus
infection. Thus, alteration of conserved V2 residues near or within
the twin-cysteine motif can significantly reduce the ability of Env
to mediate SIVmac239 infection.
Changes in the Twin Cysteines Reduce Cell-cell Fusion
We tested the ability of the SIVmac239 mutants to mediate cell-
cell fusion. The twin-cysteine mutants were significantly reduced
in their cell-cell fusion ability, along with the 192Y/A mutant
(Figure 3). The 190R/E mutant supported cell-cell fusion as
efficiently as the wild-type SIVmac239 Env. Thus, the cell-cell
fusion data correlate nicely with the single-round virus infection
data, suggesting that the twin-cysteine and 192Y/A mutants
exhibit decreased Env functionality in mediating membrane
fusion.
Figure 2. Infectivity of the twin-cysteine mutants and other
gp120 V2 region mutants of SIVmac239. Viruses pseudotyped
with the wild-type (wt) and mutant SIVmac239 Envs were made with a
GFP-expressing vector and used to infect TZM-bl target cells. The
infectivity was evaluated by measuring the fluorescence intensity of
GFP by flow cytometry.
doi:10.1371/journal.pone.0069406.g002
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Twin-cysteine Changes do not Affect Receptor Binding
To investigate the mechanism of the observed decreases in
SIVmac239 Env function, we examined the binding of radiola-
beled gp120 to the receptors, CD4 and CCR5. The CCR5
binding experiments were carried out in the presence of soluble
CD4. Neither CD4 nor CCR5 binding were affected significantly
by the introduced changes (Figure 4), as determined by statistical
analysis using GraphPad Prism software where p,0.05 was
considered significant. Thus, the changes in the V2 region did not
globally disrupt the conformation of monomeric gp120, which is
required for binding both receptors.
Twin-cysteine Changes Cause gp120 Shedding
Because of the association of the V2 region with the gp120
TAD, we hypothesized that the twin cysteines may contribute to
stabilization of the Env trimer. We examined Env trimer stability
by determining the amount of the Env glycoprotein precursor
(gp160) and mature gp120 glycoprotein in the cells, as well as shed
gp120 in the medium of Env-expressing cells. As shown in
Figure 5A, all the SIVmac239 mutants expressed Env well and
also processed the gp160 precursor efficiently. The wild-type and
190R/E gp120 glycoproteins were primarily cell-associated, with a
relatively small amount of shed gp120 detectable in the medium.
By contrast, the single-cysteine mutants 183C/A and 191C/A, the
double-cysteine mutant (183C/A+191C/A), and the 192Y/A
mutant exhibited significantly higher levels of gp120 in the
medium compared to wild-type SIVmac239 Env. The levels of
cell-associated gp120 were dramatically reduced for these mutants.
Thus, changes in cysteines 183 and 191 or the adjacent conserved
tyrosine 192 resulted in a significant decrease in the association of
gp120 with the Env trimer.
To confirm the above results, we conducted a pulse-chase
experiment on cells expressing the wild-type and mutant
SIVmac239 Envs (Figure 5B). A slight delay in the rate of gp160
precursor processing was observed for the twin-cysteine mutants
and the 192Y/A mutant, relative to the wild-type SIVmac239
Env. These mutant gp120 glycoproteins were shed into the
medium soon after proteolytic processing of the gp160 Env
precursor. These results support the observation that changes in
the twin cysteines decrease the association of SIVmac239 gp120
with the Env trimer.
Discussion
Here we show that alteration of the twin-cysteine motif disrupts
the stable and non-covalent association of SIVmac239 gp120 with
the Env trimer. Presumably as a result of the instability of the
mutant Env trimers, these Env mutants exhibit very poor function
in cell-cell fusion or virus entry. We suggest that the twin cysteines
may form a disulfide-bond to stabilize the Env trimer. This
disulfide bond could be formed either within the gp120 subunit or
between adjacent subunits. Although there is currently no
evidence for inter-protomer disulfide bonds in the SIVmac239
Env trimer, the close association of the V2 regions in the gp120
TAD raises this possibility. Future studies will explore the
formation and biological relevance of disulfide bonds between
Env protomers. The adjacent tyrosine 192 of the twin-cysteine
motif is markedly conserved in SIV, HIV-2 and HIV-1, and
change of this residue also interrupts the trimer association. It is
indicated that this tyrosine 192 may also play an important role in
the Env trimer stabilization.
The twin cysteines in the V2 regions of the gp120 trimer
association domain are very conserved in SIV and HIV-2, but are
not present in any HIV-1 strains. The majority of SIVcpz strains
lack these two cysteine residues, whereas some strains have two
cysteine residues in the same vicinity. The twin cysteines appear to
have evolved in several SIV lineages, but were minimally retained
in SIVcpz and then lost completely in HIV-1. Of interest, during
zoonotic transmission from monkeys and establishment in
hominoids, PLVs became progressively more dependent on
CD4. This increased dependence on CD4 was accompanied by
changes in the Phe 43 cavity and inner domain of gp120 [8–11].
These changes are predicted to make the gp120 core of HIV-1 less
Figure 3. Cell-cell fusion mediated by SIVmac239 Env variants.
The cell-cell fusion assay was performed by measuring the fluorescence
intensity of Tat-inducible luciferase resulting from fusion of the
SIVmac239 Env-expressing cells with target TZM-bl cells.
doi:10.1371/journal.pone.0069406.g003
Figure 4. Receptor binding of SIVmac239 Env variants. The
assay measuring gp120 binding to human CD4 and human CCR5
utilized 35S-radiolabeled gp120 precipitated with CD4-Ig or incubated
with CCR5-expressing cells in the presence of soluble CD4.
doi:10.1371/journal.pone.0069406.g004
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prone to assume the CD4-bound conformation than the SIV
gp120 core. The propensity of the gp120 core to adopt the CD4-
bound conformation is restrained by the V1/V2 and V3 regions
(the TAD) in the unliganded Env trimer [8–11]. Given the greater
propensity of the SIV gp120 core to assume the CD4-bound state,
it is tempting to speculate that the SIVs required more stable TAD
association to prevent premature triggering of Env. The ability of
the twin-cysteine pair to form a disulfide bond may stabilize TAD
inter-protomer interactions and help to maintain the unliganded
state of the Env trimer.
Modulation of Env trimer stability may have implications for
viral evasion of the host immune response and pathogenicity. The
added TAD stability that SIV and HIV-2 gain from structural
elements like the twin cysteines may influence the elicitation and
efficiency of neutralizing antibodies. Although SIV and HIV-2
elicit a host immune response in the form of neutralizing
antibodies, both viruses persist, achieving a balance between virus
infection and the host immune reaction. As a result, SIV does not
typically cause serious disease in monkey hosts. Similarly, HIV-2
infection in humans is much less likely to progress to full-blown
AIDS than HIV-1 infection. As CD4-dependence is associated
with greater resistance to neutralization antibodies, HIV-1 may
have evolved greater CD4 dependence to escape host immune
responses. Poorer host control of HIV-1 is consistent with its
pathogenicity. Investigating the functional phenotypes associated
with Env diversity in the HIV-1 and HIV-2/SIV lineages should
lead to a better understanding of PLV pathogenesis in primate
species.
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